Mouse models of triplet repeat diseases

被引:17
作者
Bates, GP [1 ]
Gonitel, R [1 ]
机构
[1] Kings Coll London, Dept Med & Mol Genet, GKT Sch Med, Guys Hosp, London SE1 9RT, England
基金
英国惠康基金;
关键词
triplet repeat expansion; mouse models; polyglutamine disease; fragile X syndrome; myotonic dystrophy; Friedreich's ataxia;
D O I
10.1385/MB:32:2:147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Triplet repeat expansions were first discovered in 1991 and since then have been found to be the mutation underlying a range of neurodegenerative, neuromuscular, and cognitive disorders including fragile X syndrome, myotonic dystrophy, Friedreich's ataxia, and the poly-glutamine disorders that include Huntington's disease. The repeats exert their detrimental effects through different molecular mechanisms dependent on whether the are located in coding or noncoding regions of the gene in question. During the past 10 yr, a wide range of strategies have been used to successfully establish mouse models for all of these disorders. This review presents an overview of these mouse models, discusses the insights into the molecular patho-genesis of these disorders that have been gained from their analysis and the strategies that are being used to uncover novel therapeutic options.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 138 条
[1]   Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice [J].
Abel, A ;
Walcott, J ;
Woods, J ;
Duda, J ;
Merry, DE .
HUMAN MOLECULAR GENETICS, 2001, 10 (02) :107-116
[2]  
Adachi H, 2003, J NEUROSCI, V23, P2203
[3]   Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death [J].
Adachi, H ;
Kume, A ;
Li, M ;
Nakagomi, Y ;
Niwa, H ;
Do, J ;
Sang, C ;
Kobayashi, Y ;
Doyu, M ;
Sobue, G .
HUMAN MOLECULAR GENETICS, 2001, 10 (10) :1039-1048
[4]   GAA repeat instability in Friedreich ataxia YAC transgenic mice [J].
Al-Mahdawi, S ;
Pinto, RM ;
Ruddle, P ;
Carroll, C ;
Webster, Z ;
Pook, M .
GENOMICS, 2004, 84 (02) :301-310
[5]   Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease [J].
Andreassen, OA ;
Dedeoglu, A ;
Ferrante, RJ ;
Jenkins, BG ;
Ferrante, KL ;
Thomas, M ;
Friedlich, A ;
Browne, SE ;
Schilling, G ;
Borchelt, DR ;
Hersch, SM ;
Ross, CA ;
Beal, MF .
NEUROBIOLOGY OF DISEASE, 2001, 8 (03) :479-491
[6]   Lipoic acid improves survival in transgenic mouse models of Huntington's disease [J].
Andreassen, OA ;
Ferrante, RJ ;
Dedeoglu, A ;
Beal, MF .
NEUROREPORT, 2001, 12 (15) :3371-3373
[7]  
BAILEY CD, 2005, IN PRESS NEUROBIOL A
[8]  
BAKKER CE, 1994, CELL, V78, P23
[9]   DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model [J].
Berul, CI ;
Maguire, CT ;
Aronovitz, MJ ;
Greenwood, J ;
Miller, C ;
Gehrmann, J ;
Housman, D ;
Mendelsohn, ME ;
Reddy, S .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (04) :R1-R7
[10]   Instability of a (CGG)98 repeat in the Fmr1 promoter [J].
Bontekoe, CJM ;
Bakker, CE ;
Nieuwenhuizen, IM ;
van der Linde, H ;
Lans, H ;
de Lange, D ;
Hirst, MC ;
Oostra, BA .
HUMAN MOLECULAR GENETICS, 2001, 10 (16) :1693-1699